Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand (2020)
Attributed to:
Meeting the UK demand for COVID19/SARS-CoV-2 vaccines via integrated manufacturing and supply chain optimisation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/vaccines9010003
Publication URI: http://dx.doi.org/10.3390/vaccines9010003
Type: Journal Article/Review
Parent Publication: Vaccines
Issue: 1